StockNews.com Initiates Coverage on Senseonics (NYSE:SENS)

StockNews.com started coverage on shares of Senseonics (NYSE:SENS) in a report released on Wednesday. The firm issued a sell rating on the stock.

Separately, HC Wainwright reissued a “buy” rating and set a $2.00 target price on shares of Senseonics in a research note on Friday, November 15th.

Senseonics Stock Up 4.0 %

NYSE:SENS opened at $0.46 on Wednesday. Senseonics has a 1 year low of $0.25 and a 1 year high of $0.75. The stock has a 50-day moving average price of $0.34 and a two-hundred day moving average price of $0.38. The stock has a market cap of $273.73 million, a price-to-earnings ratio of -3.54 and a beta of 0.77. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17.

Insider Activity at Senseonics

In other news, CEO Timothy T. Goodnow bought 315,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The shares were acquired at an average price of $0.31 per share, with a total value of $97,650.00. Following the transaction, the chief executive officer now owns 11,310,355 shares in the company, valued at $3,506,210.05. This represents a 2.86 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Frederick T. Sullivan purchased 124,933 shares of Senseonics stock in a transaction on Thursday, December 12th. The shares were purchased at an average cost of $0.38 per share, with a total value of $47,474.54. Following the transaction, the chief financial officer now owns 2,478,844 shares in the company, valued at approximately $941,960.72. The trade was a 5.31 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the business. Geode Capital Management LLC boosted its stake in shares of Senseonics by 3.2% during the 3rd quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock worth $2,042,000 after buying an additional 179,103 shares during the last quarter. FMR LLC boosted its position in Senseonics by 48,267.2% during the third quarter. FMR LLC now owns 168,318 shares of the company’s stock valued at $59,000 after purchasing an additional 167,970 shares during the last quarter. GSA Capital Partners LLP bought a new position in Senseonics in the third quarter valued at approximately $117,000. Symmetry Partners LLC acquired a new position in shares of Senseonics during the 3rd quarter worth approximately $164,000. Finally, Cubist Systematic Strategies LLC raised its stake in shares of Senseonics by 25.9% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock worth $166,000 after purchasing an additional 85,501 shares in the last quarter. Institutional investors own 12.36% of the company’s stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.